Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023162095> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2023162095 endingPage "6" @default.
- W2023162095 startingPage "6" @default.
- W2023162095 abstract "Aim: Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) treatment failure is a rigorous problem in patients with diffuse large B-cell lymphoma (DLBCL), which usually predicts poor survival. The study explored the association of microRNAs with R-CHOP resistance in order to find reliable predictive factors and novel therapeutic targets. Methods: Forty-five newly diagnosed cases with DLBCL were administered with R-CHOP regimen. Thirty-three of them were divided into the sensitive group and 12 of them into the resistant group based on their response to the treatment. Both microRNAs and gene expression profilings were examined with microarray in these patients. Results: Six microRNAs were found to have significant difference between R-CHOP sensitive and resistant groups, including microRNA-9, microRNA-146a, microRNA-363, microRNA-488, microRNA-548d-3p, and microRNA-219-1-3p (P 1). Multivariate analysis showed that both microRNA-146a and microRNA-548d-3p were inversely correlated with resistance while microRNA-363 and microRNA-219-1-3p were directly correlated with resistance. Although both molecular subtypes based on cellular origin (Pearson correlation = 0.368, P = 0.023) and multiple extranodal involvement (Pearson correlation = 0.352, P = 0.030) manifested the association with R-CHOP resistance, these specific microRNAs remained independent predictors of clinical outcome in multivariate analysis. In addition, microRNA-146a was proved to have linkages with multiple extranodal involvements. Molecular subtypes based on a cellular origin were not verified to correlate with specific microRNAs. These specific microRNAs could predict resistance in 92.1% of patients in the present study. Conclusion: The expression of specific microRNAs may serve as useful biomarker for prediction of response to R-CHOP therapy in patients with DLBCL." @default.
- W2023162095 created "2016-06-24" @default.
- W2023162095 creator A5005085650 @default.
- W2023162095 creator A5011450428 @default.
- W2023162095 creator A5029493707 @default.
- W2023162095 creator A5039471367 @default.
- W2023162095 creator A5045950262 @default.
- W2023162095 creator A5048662409 @default.
- W2023162095 creator A5063077563 @default.
- W2023162095 creator A5066884310 @default.
- W2023162095 creator A5086231834 @default.
- W2023162095 creator A5090455604 @default.
- W2023162095 date "2015-01-01" @default.
- W2023162095 modified "2023-10-18" @default.
- W2023162095 title "MicroRNAs are Related to Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Resistance in Patients with Diffuse Large B-cell Lymphoma" @default.
- W2023162095 doi "https://doi.org/10.4103/2395-3977.151470" @default.
- W2023162095 hasPublicationYear "2015" @default.
- W2023162095 type Work @default.
- W2023162095 sameAs 2023162095 @default.
- W2023162095 citedByCount "3" @default.
- W2023162095 countsByYear W20231620952016 @default.
- W2023162095 countsByYear W20231620952017 @default.
- W2023162095 countsByYear W20231620952022 @default.
- W2023162095 crossrefType "journal-article" @default.
- W2023162095 hasAuthorship W2023162095A5005085650 @default.
- W2023162095 hasAuthorship W2023162095A5011450428 @default.
- W2023162095 hasAuthorship W2023162095A5029493707 @default.
- W2023162095 hasAuthorship W2023162095A5039471367 @default.
- W2023162095 hasAuthorship W2023162095A5045950262 @default.
- W2023162095 hasAuthorship W2023162095A5048662409 @default.
- W2023162095 hasAuthorship W2023162095A5063077563 @default.
- W2023162095 hasAuthorship W2023162095A5066884310 @default.
- W2023162095 hasAuthorship W2023162095A5086231834 @default.
- W2023162095 hasAuthorship W2023162095A5090455604 @default.
- W2023162095 hasConcept C126322002 @default.
- W2023162095 hasConcept C143998085 @default.
- W2023162095 hasConcept C2776694085 @default.
- W2023162095 hasConcept C2776755627 @default.
- W2023162095 hasConcept C2778559949 @default.
- W2023162095 hasConcept C2778720950 @default.
- W2023162095 hasConcept C2779338263 @default.
- W2023162095 hasConcept C2779429289 @default.
- W2023162095 hasConcept C2780653079 @default.
- W2023162095 hasConcept C2781303535 @default.
- W2023162095 hasConcept C502942594 @default.
- W2023162095 hasConcept C71924100 @default.
- W2023162095 hasConceptScore W2023162095C126322002 @default.
- W2023162095 hasConceptScore W2023162095C143998085 @default.
- W2023162095 hasConceptScore W2023162095C2776694085 @default.
- W2023162095 hasConceptScore W2023162095C2776755627 @default.
- W2023162095 hasConceptScore W2023162095C2778559949 @default.
- W2023162095 hasConceptScore W2023162095C2778720950 @default.
- W2023162095 hasConceptScore W2023162095C2779338263 @default.
- W2023162095 hasConceptScore W2023162095C2779429289 @default.
- W2023162095 hasConceptScore W2023162095C2780653079 @default.
- W2023162095 hasConceptScore W2023162095C2781303535 @default.
- W2023162095 hasConceptScore W2023162095C502942594 @default.
- W2023162095 hasConceptScore W2023162095C71924100 @default.
- W2023162095 hasIssue "1" @default.
- W2023162095 hasLocation W20231620951 @default.
- W2023162095 hasOpenAccess W2023162095 @default.
- W2023162095 hasPrimaryLocation W20231620951 @default.
- W2023162095 hasRelatedWork W160156331 @default.
- W2023162095 hasRelatedWork W1989464859 @default.
- W2023162095 hasRelatedWork W2396623636 @default.
- W2023162095 hasRelatedWork W3011149924 @default.
- W2023162095 hasRelatedWork W3026939985 @default.
- W2023162095 hasRelatedWork W3212185513 @default.
- W2023162095 hasRelatedWork W4234573302 @default.
- W2023162095 hasRelatedWork W4250500771 @default.
- W2023162095 hasRelatedWork W4284698212 @default.
- W2023162095 hasRelatedWork W4310107958 @default.
- W2023162095 hasVolume "1" @default.
- W2023162095 isParatext "false" @default.
- W2023162095 isRetracted "false" @default.
- W2023162095 magId "2023162095" @default.
- W2023162095 workType "article" @default.